Failure of Perivascular Drainage of -amyloid in Cerebral Amyloid Angiopathy

被引:123
|
作者
Hawkes, Cheryl A. [1 ]
Jayakody, Nimeshi [1 ]
Johnston, David A. [1 ]
Bechmann, Ingo [2 ]
Carare, Roxana O. [1 ]
机构
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany
基金
英国生物技术与生命科学研究理事会;
关键词
Alzheimer's disease; amyloid; cerebral amyloid angiopathy; interstitial fluid neuroimmunology; perivascular drainage; CONVECTION-ENHANCED DELIVERY; INTERSTITIAL FLUID DRAINAGE; BETA FIBRIL FORMATION; ALZHEIMERS-DISEASE; A-BETA; APOLIPOPROTEIN-E; BASEMENT-MEMBRANES; TRANSFORMING GROWTH-FACTOR-BETA-1; CEREBROVASCULAR PATHOLOGY; SCAVENGER RECEPTOR;
D O I
10.1111/bpa.12159
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Alzheimer's disease, amyloid- (A) accumulates as insoluble plaques in the brain and deposits in blood vessel walls as cerebral amyloid angiopathy (CAA). The severity of CAA correlates with the degree of cognitive decline in dementia. The distribution of A in the walls of capillaries and arteries in CAA suggests that A is deposited in the perivascular pathways by which interstitial fluid drains from the brain. Soluble A from the extracellular spaces of gray matter enters the basement membranes of capillaries and drains along the arterial basement membranes that surround smooth muscle cells toward the leptomeningeal arteries. The motive force for perivascular drainage is derived from arterial pulsations combined with the valve effect of proteins present in the arterial basement membranes. Physical and biochemical changes associated with arteriosclerosis, aging and possession of apolipoprotein E4 genotype lead to a failure of perivascular drainage of soluble proteins, including A. Perivascular cells associated with arteries and the lymphocytes recruited in the perivenous spaces contribute to the clearance of A. The failure of perivascular clearance of A may be a major factor in the accumulation of A in CAA and may have significant implications for the design of therapeutics for the treatment of Alzheimer's disease.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 50 条
  • [31] Cerebral Amyloid Angiopathy
    Yamada, Masahito
    Naiki, Hironobu
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 41 - 78
  • [32] Cerebral amyloid angiopathy
    Rosand, J
    Greenberg, SM
    NEUROLOGIST, 2000, 6 (06) : 315 - 325
  • [33] APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function
    Xiong, Monica
    Jiang, Hong
    Serrano, Javier Remolina
    Gonzales, Ernesto R.
    Wang, Chao
    Gratuze, Maud
    Hoyle, Rosa
    Bien-Ly, Nga
    Silverman, Adam P.
    Sullivan, Patrick M.
    Watts, Ryan J.
    Ulrich, Jason D.
    Zipfel, Gregory J.
    Holtzman, David M.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (581)
  • [34] Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces
    van Veluw, Susanne J.
    Biessels, Geert Jan
    Bouvy, Willem H.
    Spliet, Wim G. M.
    Zwanenburg, Jaco J. M.
    Luijten, Peter R.
    Macklin, Eric A.
    Rozemuller, Annemieke J. M.
    Gurol, M. Edip
    Greenberg, Steven M.
    Viswanathan, Anand
    Martinez-Ramirez, Sergi
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (03) : 576 - 580
  • [35] Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy
    Love, Seth
    Miners, Scott
    Palmer, Jen
    Chalmers, Katy
    Kehoe, Patrick
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 4778 - 4792
  • [36] Cerebral Amyloid Angiopathy
    Szidonya, Laszlo
    Nickerson, Joshua P.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2023, 61 (03) : 551 - 562
  • [37] Complement Activation in Capillary Cerebral Amyloid Angiopathy
    Matsuo, Ko
    Shindo, Akihiro
    Niwa, Atsushi
    Tabei, Ken-ichi
    Akatsu, Hiroyasu
    Hashizume, Yoshio
    Akiyama, Haruhiko
    Ayaki, Takashi
    Maki, Takakuni
    Sawamoto, Nobukatsu
    Takahashi, Ryosuke
    Oikawa, Shinji
    Tomimoto, Hidekazu
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2017, 44 (5-6) : 343 - 353
  • [38] Severe pathological manifestation of cerebral amyloid angiopathy correlates with poor outcome from cerebral amyloid angiopathy related intracranial hemorrhage
    Tang Ya-juan
    Wang Shuo
    Zhu Ming-wei
    Sun Yi-lin
    Zhao Ji-zong
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 603 - 608
  • [39] Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy
    Martinez-Ramirez, Sergi
    van Rooden, Sanneke
    Charidimou, Andreas
    van Opstal, Anna Maria
    Wermer, Marieke
    Gurol, M. Edip
    Terwindt, Gisela
    van der Grond, Jeroen
    Greenberg, Steven M.
    van Buchem, Mark
    Viswanathan, Anand
    STROKE, 2018, 49 (08) : 1913 - 1919
  • [40] Clinical significance of amyloid positivity in patients with probable cerebral amyloid angiopathy markers
    Jang, Hyemin
    Jang, Young Kyoung
    Kim, Hee Jin
    Werring, David John
    Lee, Jin San
    Choe, Yeong Sim
    Park, Seongbeom
    Lee, Juyeon
    Kim, Ko Woon
    Kim, Yeshin
    Cho, Soo Hyun
    Kim, Si Eun
    Kim, Seung Joo
    Charidimou, Andreas
    Na, Duk L.
    Seo, Sang Won
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (06) : 1287 - 1298